|
1
|
Robinson BM: Malignant pleural
mesothelioma: An epidemiological perspective. Ann Cardiothorac
Surg. 1:491–496. 2012.PubMed/NCBI
|
|
2
|
Campbell K, Brosseau S, Reviron-Rabec L,
Bergot E, Lechapt E, Levallet G and Zalcman G: Malignant pleural
mesothelioma: 2013 state of the art. Bull Cancer. 100:1283–1293.
2013.PubMed/NCBI
|
|
3
|
Federico R, Adolfo F, Giuseppe M, Lorenzo
S, Martino DT, Anna C, Adriano P, Gino C, Francesca R and Matteo C:
Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by
surgery and radiation in the treatment of pleural mesothelioma. BMC
Cancer. 13:222013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rusch V, Baldini EH, Bueno R, De Perrot M,
Flores R, Hasegawa S, Klepetko W, Krug L, Lang-Lazdunski L, Pass H,
et al: The role of surgical cytoreduction in the treatment of
malignant pleural mesothelioma: Meeting summary of the
international mesothelioma interest group congress, September
11–14, 2012, Boston, Mass. J Thorac Cardiovasc Surg. 145:909–910.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wolf AS, Daniel J and Sugarbaker DJ:
Surgical techniques for multimodality treatment of malignant
pleural mesothelioma: Extrapleural pneumonectomy and
pleurectomy/decortication. Semin Thorac Cardiovasc Surg.
21:132–148. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yan TD, Boyer M, Tin MM, Wong D, Kennedy
C, McLean J, Bannon PG and McCaughan BC: Extrapleural pneumonectomy
for malignant pleural mesothelioma: Outcomes of treatment and
prognostic factors. J Thorac Cardiovasc Surg. 138:619–624. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sugarbaker DJ, Jaklitsch MT, Bueno R,
Richards W, Lukanich J, Mentzer SJ, Colson Y, Linden P, Chang M,
Capalbo L, et al: Prevention, early detection, and management of
complications after 328 consecutive extrapleural pneumonectomies. J
Thorac Cardiovasc Surg. 128:138–146. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sugarbaker DJ and Wolf AS: Surgery for
malignant pleural mesothelioma. Expert Rev Respir Med. 4:363–372.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Flores RM, Pass HI, Seshan VE, Dycoco J,
Zakowski M, Carbone M, Bains MS and Rusch VW: Extrapleural
pneumonectomy versus pleurectomy/decortication in the surgical
management of malignant pleural mesothelioma: Results in 663
patients. J Thorac Cardiovasc Surg. 135:620–626. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Friedberg JS, Mick R, Culligan M,
Stevenson J, Fernandes A, Smith D, Glatstein E, Hahn SM and Cengel
K: Photodynamic therapy and the evolution of a lung-sparing
surgical treatment for mesothelioma. Ann Thorac Surg. 91:1738–1745.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cao C, Tian D, Park J, Allan J, Pataky KA
and Yan TD: A systematic review and meta-analysis of surgical
treatments for malignant pleural mesothelioma. Lung Cancer.
83:240–245. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Taioli E, Wolf AS and Flores RM:
Meta-analysis of survival after pleurectomy decortication versus
extrapleural pneumonectomy in mesothelioma. Ann Thorac Surg.
99:472–480. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rusch VW: A proposed new international TNM
staging system for malignant pleural mesothelioma. From the
international mesothelioma interest group. Chest. 108:1122–1128.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rice D, Rusch V, Pass H, Asamura H, Nakano
T, Edwards J, Giroux DJ, Hasegawa S, Kernstine KH, Waller D, et al:
Recommendations for uniform definitions of surgical techniques for
malignant pleural mesothelioma: A consensus report of the
international association for the study of lung cancer
international staging committee and the international mesothelioma
interest group. J Thorac Oncol. 6:1304–1312. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Clavien PA, Barkun J, de Oliveira ML,
Vauthey JN, Dindo D, Schulick RD, de Santibañes E, Pekolj J,
Slankamenac K, Bassi C, et al: The Clavien-Dindo classification of
surgical complications: Five-year experience. Ann Surg.
250:187–196. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Society TJLC: General rule for clinical
and pathological record of lung cancer. 8th. Kanehara; Tokyo: 2017,
(In Japanese).
|
|
17
|
Sugarbaker DJ, Flores RM, Jaklitsch MT,
Richards WG, Strauss GM, Corson JM, DeCamp MM Jr, Swanson SJ, Bueno
R, Lukanich JM, et al: Resection margins, extrapleural nodal
status, and cell type determine postoperative long-term survival in
trimodality therapy of malignant pleural mesothelioma: Results in
183 patients. J Thorac Cardiovasc Surg. 117:54–63. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yan TD, Boyer M, Tin MM, Sim J, Kennedy C,
McLean J, Bannon PG, McCaughan BC, et al: Prognostic features of
long-term survivors after surgical management of malignant pleural
mesothelioma. Ann Thorac Surg. 87:1552–1556. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tsutani Y, Takuwa T, Miyata Y, Fukuoka K,
Hasegawa S, Nakano T and Okada M: Prognostic significance of
metabolic response by positron emission tomography after
neoadjuvant chemotherapy for resectable malignant pleural
mesothelioma. Ann Oncol. 24:1005–1010. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lang-Lazdunski L, Bille A, Lal R, Cane P,
McLean E, Landau D, Steele J and Spicer J:
Pleurectomy/decortication is superior to extrapleural pneumonectomy
in the multimodality management of patients with malignant pleural
mesothelioma. J Thorac Oncol. 7:737–743. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Burt BM, Cameron RB, Mollberg NM, Kosinski
AS, Schipper PH, Shrager JB and Vigneswaran WT: Malignant pleural
mesothelioma and the society of thoracic surgeons database: An
analysis of surgical morbidity and mortality. J Thorac Cardiovasc
Surg. 148:30–35. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nakas A, von Meyenfeldt E, Lau K, Muller S
and Waller D: Long-term survival after lung-sparing total
pleurectomy for locally advanced (international mesothelioma
interest group stage T3-T4) non-sarcomatoid malignant pleural
mesothelioma. Eur J Cardiothorac Surg. 41:1031–1036. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Okada M, Mimura T, Ohbayashi C, Sakuma T,
Soejima T and Tsubota N: Radical surgery for malignant pleural
mesothelioma: Results and prognosis. Interact Cardiovasc Thorac
Surg. 7:102–106. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Allen AM, Den R, Wong JS, Zurakowski D,
Soto R, Jänne PA, Zellos L, Bueno R, Sugarbaker DJ and Baldini EH:
Influence of radiotherapy technique and dose on patterns of failure
for mesothelioma patients after extrapleural pneumonectomy. Int J
Radiat Oncol Biol Phys. 68:1366–1374. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Stevens CW, Wong PF, Rice D, Jeter M,
Forster K and Zhu XR: Treatment planning system evaluation for
mesothelioma IMRT. Lung Cancer. 49:S75–S81. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Flores RM: Surgical options in malignant
pleural mesothelioma: Extrapleural pneumonectomy or
pleurectomy/decortication. Semin Thorac Cardiovasc Surg.
21:149–153. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Weder W, Stahel RA, Bernhard J, Bodis S,
Vogt P, Ballabeni P, Lardinois D, Betticher D, Schmid R, Stupp R,
et al: Multicenter trial of neo-adjuvant chemotherapy followed by
extrapleural pneumonectomy in malignant pleural mesothelioma. Ann
Oncol. 18:1196–1202. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Batirel HF, Metintas M, Caglar HB,
Yildizeli B, Lacin T, Bostanci K, Akgul AG, Evman S and Yuksel M:
Trimodality treatment of malignant pleural mesothelioma. J Thorac
Oncol. 3:499–504. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kostron A, Friess M, Inci I, Hillinger S,
Schneiter D, Gelpke H, Stahel R, Seifert B, Weder W and Opitz I:
Propensity matched comparison of extrapleural pneumonectomy and
pleurectomy/decortication for mesothelioma patients. Interact
Cardiovasc Thorac Surg. 24:740–746. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Infante M, Morenghi E, Bottoni E, Zucali
P, Rahal D, Morlacchi A, Ascolese AM, De Rose F, Navarria P,
Crepaldi A, et al: Comorbidity, postoperative morbidity and
survival in patients undergoing radical surgery for malignant
pleural mesothelioma. Eur J Cardiothorac Surg. 50:1077–1082. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kostron A, Friess M, Crameri O, Inci I,
Schneiter D, Hillinger S, Stahel R, Weder W and Opitz I: Relapse
pattern and second-line treatment following multimodality treatment
for malignant pleural mesothelioma. Eur J Cardiothorac Surg.
49:1516–1523. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ploenes T, Osei-Agyemang T, Krohn A, Krohn
A, Waller CF, Duncker-Rohr V, Elze M and Passlick B: Changes in
lung function after surgery for mesothelioma. Asian Cardiovasc
Thorac Ann. 21:48–55. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bolukbas S, Eberlein M and Schirren J:
Prospective study on functional results after lung-sparing radical
pleurectomy in the management of malignant pleural mesothelioma. J
Thorac Oncol. 7:900–905. 2012. View Article : Google Scholar : PubMed/NCBI
|
